Pharmaceuticals

Industry Trends Show Pharmaceutical Suppositories Market Set to Expand at 9.6% CAGR Until 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Current and Projected Market Size of the Pharmaceutical Suppositories Industry?#_x000D_

The market size for anti-cancer MAbS has experienced robust growth in the past few years. Currently, it is projected to expand from $65.35 billion in 2024 to $71.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.0%. The substantial growth during the historic period can be credited to factors such as increasing cancer prevalence, enhanced comprehension of cancer biology, the rise in tailored medical treatments, augmented investment in R&D, as well as growing patient cognizance and demand._x000D_

_x000D_

The market size for anti-cancer MAbS is projected to witness a robust growth in the coming years, escalating to “$102.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%.” This expected growth in the forecast period can be linked to the progress in immunotherapy, the growing preference for combination therapies, the evolution of next-generation mAbs, worldwide initiatives to mitigate the impact of cancer, and the broadening of patient access programs. Key trends during this forecast period encompass advancements in drug delivery technologies, the incorporation of artificial intelligence in drug discovery, strategic alliances and partnerships in the pharma sector, progress in biotechnology, and car-t cell therapies._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9041&type=smp_x000D_

_x000D_

#Which Factors Are Currently Driving The Growth Of The Pharmaceutical Suppositories Market?_x000D_

The escalating occurrence of ailments is projected to drive the growth of the pharmaceutical suppositories market. The growing incidence of these conditions is largely due to elements such as climate and geography, as well as disease-carrying insects. Pharmaceutical suppositories are increasingly being used to treat the rising patient numbers resulting from this surge in disease prevalence. This type of medication provides an alternative way of administering drugs, by placing a small, cylindrical object into the body, generally via the rectum, which then dissolves or melts, thereby releasing the medication required to treat the illness. For example, chronic diseases are expected to be responsible for 70% of all deaths globally by 2030, according to an article by a US-based intergovernmental organization published by the United Nations. These chronic illnesses are predicted to account for nearly 60% of all global deaths. Therefore, the escalating occurrence of ailments is pushing the pharmaceutical suppositories market’s growth._x000D_

_x000D_

The anti-cancer mabs market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types_x000D_

2) By Application: Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications_x000D_

3) By End User: Hospitals, Research Institutes, Other End Users _x000D_

_x000D_

Subsegments:_x000D_

1) By Murine Antibodies: Murine IgG, Murine IgM, Other Murine Isotypes _x000D_

2) By Chimeric Antibodies: Chimeric IgG, Chimeric IgM, Other Chimeric Isotypes _x000D_

3) By Humanized Antibodies: Humanized IgG, Humanized IgM, Other Humanized Isotypes _x000D_

4) By Other Types: Fully Human Antibodies, Bispecific Antibodies, Conjugated Antibodies, Other Novel Formats _x000D_

_x000D_

#What Notable Trends Are Shaping The Direction Of The Pharmaceutical Suppositories Market?#_x000D_

In the anticancer mAbs market, product innovations are emerging as a significant trend. To solidify their standing in the market, major firms are introducing more potent and targeted mAbs cancer therapies. For example, Roche Holding AG, a pharmaceutical company based in Switzerland, unveiled PHESGO in May 2022. PHESGO, a unique combination of monoclonal antibody (mAb) treatment for HER2-positive early breast cancer, is a subcutaneous injection merging two mAbs, pertuzumab, and trastuzumab, with the enzyme hyaluronidase. This combination, including the enzymatic addition of hyaluronidase to enhance mAbs absorption, enables the treatment to be administered subcutaneously instead of intravenously._x000D_

_x000D_

#Who Are The Main Participants Shaping The Pharmaceutical Suppositories Market Landscape?#_x000D_

Major companies operating in the anti-cancer mabs market include Amgen Inc., Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Merck & Co. Inc., Spectrum Pharmaceuticals Inc., AstraZeneca plc., Pfizer Inc., Gilead Sciences Inc., Bayer HealthCare, ImmunoGen Inc., Genentech Inc., AbbVie Inc., Takeda Pharmaceuticals, Seattle Genetics, Regeneron Pharmaceuticals, Celgene, Ipsen, Daiichi Sankyo, Kite Pharma, ADC Therapeutics, MacroGenics Inc., BioXcel Therapeutics, Zymeworks Inc., Exelixis Inc., Blueprint Medicines, Erytech Pharma, Oncopeptides AB _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/anti-cancer-mabs-global-market-report_x000D_

_x000D_

#Which Region Currently Holds The Largest Share In The Pharmaceutical Suppositories Market?#_x000D_

North America was the largest region in the anti-cancer MAbS market in 2024. Asia-Pacific is expected to be the fastest-growing region in the anti-cancer MAbS market during the forecast period. The regions covered in the anti-cancer mAbs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9041&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_